Leap Therapeutics
LPTX
LPTX
45 hedge funds and large institutions have $5.09M invested in Leap Therapeutics in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 23
91% less capital invested
Capital invested by funds: $55.3M → $5.09M (-$50.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
45
Holding in Top 10
–
Calls
$22K
Puts
$19K
Top Buyers
| 1 | +$321K | |
| 2 | +$258K | |
| 3 | +$30.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$22.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.5K |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$3.64M | |
| 3 | -$811K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$535K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$302K |
